iRadimed (NASDAQ:IRMD) is set to give its latest quarterly earnings report on Thursday, 2022-11-03. Here's what investors need to know before the announcement.
Analysts estimate that iRadimed will report an earnings per share (EPS) of $0.24.
Iradimed Corporation (NASDAQ:IRMD) voluntarily withdrew its 510(K) application for its next-generation MRidium 3870 Infusion Pump System. Roger Susi, President and Chief…
IRADIMED CORPORATION (the "Company") (NASDAQ:IRMD) today announced that the Company voluntarily withdrew its 510(K) application on October 5, 2022, for its next-generation MR IV pump.
Roger Susi,
Snowflake Inc. (NYSE: SNOW) surged 17.4% to $187.18 in pre-market trading after the company reported better-than-expected Q2 sales results and issued product revenue guidance.
iRadimed (NASDAQ:IRMD) reported quarterly earnings of $0.45 per share. This is a 95.65 percent increase over earnings of $0.23 per share from the same period last year.